Trial Profile
A Phase I, Open-Label Study to Assess the Effects of PRC-4016 (Icosabutate) on the Pharmacokinetics of Midazolam, Omeprazole, Flurbiprofen and Simvastatin in Healthy Male/Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Icosabutate (Primary) ; Flurbiprofen; Midazolam; Omeprazole; Simvastatin
- Indications Dyslipidaemias; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors Pronova BioPharma
- 24 Feb 2015 New trial record